About Us

Dr Abhishek Behera

Dr Abhishek Behera, MBBS, MD and DM (AIIMS) Nuclear oncologist in Delhi, Gurgaon, Faridabad, Noida and NCR. Access ethical, scientific and world-class cancer care in the heart of Delhi NCR. Educational resources for cancer patients can be accessed at various sections on this website by using the menu above.

Free To Connect With Us

What makes me one of the best

Qualification And Experince

I have received my entire training from AIIMS New Delhi, the apex medical institute in the country and the mecca of health education and world-class medical treatment in India. In fact, I was a member of this institution for more than 12 years. In addition, I have been the recipient of numerous national awards. Further, I have published numerous research papers in top medical journals in the country and abroad.

Ethics And Principles

While qualifications are important, I believe what is more important is the “why” and “how” of one’s practice. Cancer is a extremely difficult diagnosis for any person and cancer treatment is often misunderstood, difficult, exhausting and expensive. Throughout my practice, I have always followed the principle of viewing my patients from a standpoint of “how would I treat my own family member?” Accordingly, I ensure that I always offer the best, most scientific, ethical and available medical care to my patients.

Certificate & Awards

Skills and areas of Expertise in Oncology

Thyroid Cancer, Neuroendocrine tumors, Prostate cancer, Pheochromocytoma& other adrenal tumoors, Paragangliomas,Liver tumors, meningiomas and other rare tumors.

Radionuclide therapy, including both beta and alpha radionuclide therapy. Expert in rare procedures such as:

  • Peptide receptor radionuclide therapy
  • PSMA therapy
  • Radioiodine (Iodine -131) therapy
  • Trans-arterial radioembolization (TARE)
  • Alpha therapy

Skilled application methods for radionuclide therapy, such asradionuclide dosimetry.

Awards and Honors

  • Ranked 1 in AIIMS DM (Therapeutic Nuclear Medicine) entrance exam (Jan 2018 session), with highest score (91%) in entrance exam among all specialities.
  • Certified Radiation Safety Officer (Nuclear Medicine) (Dec 2019)
  • Winner of “Top Reviewer” certificate for three years in a row (2018, 2019,2020) from the international journal “Nuclear Medicine Communications”.
  • Highest score in MD (Nuclear Medicine) final exam.
  • CBSE Merit Scholarship for the most meritorious students in the country.
  • All India Undergraduate ranks: AIIMS (Rank 27), AIPMT (Rank 94), DPMT (Rank 24)

Research Experience

Proper treatment of cancer is based in science. The roots of scientific treatment is based on the principles of evidence based medicine, which ensures that only the most effective, scientific treatments are offered to patients with maximum benefit and minimum harm.

Accordingly, to be a good oncologist, one should have a strong research base in addition to being a clinician. Dr Behera has numerous peer-reviewed publications in reputed Indian and International peer-reviewed journals. This includes the top 5 Nuclear Medicine journals in the world like Clinical Nuclear Medicine

Dr Abhishek has published research in some top journals

Published, available online and in print

  • Agarwal KK, Seth R, Behra A, Jana M, Kumar R. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations. Jpn J Radiol. 2016 Apr;34(4):267–76.
  • Agarwal KK, Behera A, Kumar R, Bal C. 18F-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Tuberculosis: Spectrum of Manifestations. Indian J Nucl Med IJNM Off J SocNucl Med India. 2017 Dec;32(4):316–21.
  • Tripathy S, Shamim SA, Behera A, Bal C, Kumar R. Adenoid Cystic Carcinoma of Trachea: Findings on 18F FDG Positron Emission Tomography-Computed Tomography. Indian J Nucl Med IJNM Off J SocNucl Med India. 2019 Sep;34(3):249–50.
  • Tripathy S, Behera A, Kumar A, Subudhi K, Bal C. Adrenocortical Carcinoma with Inferior Vena Cava Thrombus on 18F-FDG-PET-Computed Tomography. Indian J Nucl Med IJNM Off J SocNucl Med India. 2020 Mar;35(1):87–8.
  • Taywade SK, Damle NA, Behera A, Devasenathipathy K, Bal C, Tripathi M, et al. Comparison of 18F-Fluorocholine Positron Emission Tomography/Computed Tomography and Four-dimensional Computed Tomography in the Preoperative Localization of Parathyroid Adenomas-initial Results. Indian J EndocrinolMetab. 2017 Jun;21(3):399–403.
  • Shamim SA, Arora G, Jha P, Gupta P, Behera A, Mukherjee A, et al. Comparison of Lutetium-177 tin colloid and Rhenium-188 tin colloid radiosynovectomy in chronic knee arthritis. Nucl Med Commun. 2020 Aug;41(8):721–6.
  • Saroha K, Pandey AK, Sharma PD, Behera A, Patel C, Bal C, et al. Development and Validation of the Suprathreshold Stochastic Resonance-Based Image Processing Method for the Detection of Abdomino-pelvic Tumor on PET/CT Scans. Indian J Nucl Med IJNM Off J SocNucl Med India. 2017 Jun;32(2):103–9.
  • Behera A, Damle NA. Incremental role of 18F-fluorocholine PET/CT over technetium-99m-labeled MIBI scan in hyperparathyroidism. Indian J EndocrinolMetab. 2016 Dec;20(6):888–90.
  • Arora S, Dhull VS, Mukherjee A, Tulsyan S, Behera A, Tripathi M. Metastatic superscan on (99m)Tc-methylene diphosphonate bone scintigraphy in pediatricneuroblastoma. Indian J Nucl Med IJNM Off J SocNucl Med India. 2015 Sep;30(3):286–7.
  • Behera A, Yadav D, Singhal A, Patel C. Nuclear cardiology quiz. J PractCardiovasc Sci. 2016;2(2):126.
  • Mukherjee A, Chakraborty PS, Behera A, Bal C, Kumar R. Radiation-Induced Esophagitis Masquerading as Disease Progression in Case of Esophageal Carcinoma: A Diagnostic Dilemma Solved on Follow-up FDG PET/CT. ClinNucl Med. 2015 Jul;40(7):e380-381.
  • Damle NA, Tripathi M, Behera A, Aggarwal S, Bal C, Aggarwal S, et al. Utility of (18)F-choline photon emission tomography/computed tomography in the diagnosis of parathyroid adenoma. Indian J Nucl Med IJNM Off J SocNucl Med India. 2016 Sep;31(3):207–9.

Conference Presentations & published abstracts:

  • Co-author in abstract titled “Prospective comparison of 18F-Fluorocholine PET/CT, Dual Phase 99mTc-Sestamibi SPECT/CT, and ultrasonography I the pre-operative localization of parathyroid adenoma” presented at the Society of Nuclear Medicine & Molecular Imaging , USA, Annual Conference in San Diego, USA.
  • Presented abstract titled “Role of FDG PET-CT in symptomatic post renal transplant patients” in the 2016 annual meeting of Society of Nuclear Medicine, India, held in Ahmedabad, India.
  • Presented abstract titled “Pattern of recovery of serum TSH in patients with suppression of hypothalamic-pituitary-thyroid axis after low dose radioiodine ablation in hyperthyroid patients” in the 2019 annual meeting of Society of Nuclear Medicine, India, held in Mumbai, India

Theses:

  • Primary Investigator in MD Thesis: “Role of 18F-Fluorocholine PET/CT in the localization of hyperfunctioning parathyroid tissue in patients with primary hyperparathyroidism”
  • Primary Investigator in DM Thesis: “Pattern of recovery of Serum TSH levels in patients with TSH suppression three months after radioiodine ablation”

Educational activities

Dr Behera has participated in innumerable teaching activities throughout his career and frequently participates in seminars and conferences for mutual education and learning.